elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34243503-894AE742-A10E-4622-AAA2-B2FBED4953EC
Q34243503-894AE742-A10E-4622-AAA2-B2FBED4953EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34243503-894AE742-A10E-4622-AAA2-B2FBED4953EC
Leukemias related to treatment with DNA topoisomerase II inhibitors.
P2860
Q34243503-894AE742-A10E-4622-AAA2-B2FBED4953EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34243503-894AE742-A10E-4622-AAA2-B2FBED4953EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f6c7a3a46f6f3d51dc37862e7a86c545966c6a1
P2860
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours